Home » Stocks » ALC

Alcon, Inc. (ALC)

Stock Price: $74.18 USD 0.05 (0.07%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 36.84B
Revenue (ttm) 6.83B
Net Income (ttm) -531.00M
Shares Out 499.70M
EPS (ttm) -1.09
PE Ratio n/a
Forward PE 38.61
Dividend $0.11
Dividend Yield 0.15%
Trading Day April 16
Last Price $74.18
Previous Close $74.13
Change ($) 0.05
Change (%) 0.07%
Day's Open 74.00
Day's Range 73.65 - 74.30
Day's Volume 453,915
52-Week Range 49.74 - 76.26

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Alcon, Semtech, Upstart, and others.

Other stocks mentioned: ALXO, CURI, SMTC, UPST
3 weeks ago - CNBC

Alcon (NYSE:ALC) has observed the following analyst ratings within the last quarter:   Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 1 0 0 Somewhat Bullish 0 2 0 0 Indifferent 0 0 0 0 Som...

3 weeks ago - Benzinga

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for Annual General Meeting

3 weeks ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon to Host Virtual Capital Markets Day on March 24

1 month ago - Business Wire

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon's Sue-Jean Lin Wins 2021 Dallas CIO of the Year

1 month ago - Business Wire

Shares of Alcon (NYSE:ALC) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 8.89% over the past year to $0.41, which were in line w...

1 month ago - Benzinga

GENEVA--(BUSINESS WIRE)--Alcon Reports Fourth Quarter and Full Year 2020 Results

1 month ago - Business Wire

Alcon, Inc. (ALC) Presents at JPMorgan Healthcare Conference - (Transcript)

3 months ago - Seeking Alpha

Eye-care devices market is an attractive end-market supported by secular growth trends such as aging population, increased myopia prevalence, and innovation in products leading to better outcomes for pa...

4 months ago - Seeking Alpha

Alcon, Inc. (ALC) CEO David Endicott on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Unable to provide full-year guidance due to difficult market conditions, Alcon CEO says

YouTube video

Alcon CEO David Endicott discusses the company's third-quarter earnings.

5 months ago - CNBC International TV

Shares of Alcon (NYSE:ALC) rose 2.73% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 15.22% year over year to $0.39, which beat the estimat...

5 months ago - Benzinga

Alcon Inc. (ALC) CEO David Endicott on Q2 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

Alcon Inc. (ALC) CEO David Endicott on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Alcon, Inc. (ALC) CEO David Endicott on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

The switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.

Other stocks mentioned: GSK
1 year ago - The Motley Fool

About ALC

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR sur... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1945
CEO
David J. Endicott
Employees
23,655
Stock Exchange
NYSE
Ticker Symbol
ALC
Full Company Profile

Financial Performance

In 2020, Alcon's revenue was $6.83 billion, a decrease of -8.99% compared to the previous year's $7.51 billion. Losses were -$531.00 million, -19.05% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Alcon is 76.45, which is an increase of 3.06% from the latest price.

Price Target
$76.45
(3.06% upside)